AI Startup Ultromics Tackles Gender Bias in Heart Disease Diagnosis
MedCity News
|
Contributed by: Kate Gamble
Summary
recognize and often misdiagnosed, particularly in women. The American Heart Association's investment in Ultromics highlights a critical shift towards leveraging artificial intelligence to bridge the diagnostic gap in cardiology, where gender bias has historically led to significant disparities in care. This focus on innovation is essential for improving outcomes for women, as it aims to enhance the accuracy of diagnoses, ensuring timely and appropriate treatment. By addressing these issues, healthcare professionals can better manage heart diseases in women, ultimately reducing mortality rates and improving quality of life.
